5th edn, (Freeman, W.H
These are due to finish in May 2026
it was FDA-approved in November 2023 for adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition
[PMID: 25709639] PubMed record related to this compound for laboratory literature review
Reference: Enhanced HGF with increased receptor affinity and nitration-dysfunction resistance through interaction with lipoic acid trisulfide by Kahona Zushi, Miyumi Seki, Ryota Mizuochi, Kazuki Shitamitsu, Alaa Elgaabari, Sakiho Tanaka, Junri Miyamoto, Kaoru Mizoguchi, Reina Fujimaru, Jiaxi Han, Takashi Nakashima, Shoko Sawano, Wataru Mizunoya, Takahiro Maeno, Issei Yokoyama, Takahiro Suzuki, Judy E
Use is restricted to qualified professionals operating in certified laboratory settings